Response to Cueto-González et al

Affiliations

¹ Institute of Medical Genetics, University of Zurich, Zurich, Switzerland. Electronic address: paolo.zanoni@uzh.ch.
² Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.
³ Institute of Medical Genetics, University of Zurich, Zurich, Switzerland; Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland. Electronic address: anita.rauch@medgen.uzh.ch.

Free article

Comment

Paolo Zanoni et al. Genet Med. 2022 Mar.

Free article

. 2022 Mar;24(3):757.

doi: 10.1016/j.gim.2021.11.006. Epub 2021 Dec 7.

¹ Institute of Medical Genetics, University of Zurich, Zurich, Switzerland. Electronic address: paolo.zanoni@uzh.ch.
² Institute of Medical Genetics, University of Zurich, Zurich, Switzerland.
³ Institute of Medical Genetics, University of Zurich, Zurich, Switzerland; Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland. Electronic address: anita.rauch@medgen.uzh.ch.

No abstract available

Conflict of interest statement

Conflict of Interest The authors declare no conflict of interest.

Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.
Zanoni P, Steindl K, Sengupta D, Joset P, Bahr A, Sticht H, Lang-Muritano M, van Ravenswaaij-Arts CMA, Shinawi M, Andrews M, Attie-Bitach T, Maystadt I, Belnap N, Benoit V, Delplancq G, de Vries BBA, Grotto S, Lacombe D, Larson A, Mourmans J, Õunap K, Petrilli G, Pfundt R, Ramsey K, Blok LS, Tsatsaris V, Vitobello A, Faivre L, Wheeler PG, Wevers MR, Wojcik M, Zweier M, Gozani O, Rauch A. Zanoni P, et al. Genet Med. 2021 Aug;23(8):1474-1483. doi: 10.1038/s41436-021-01158-1. Epub 2021 May 3. Genet Med. 2021. PMID: 33941880 Free PMC article.
Correspondence on "Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype" by Zanoni et al.
Cueto-González AM, Fernández-Álvarez P, Palafoll IV, Lasa-Aranzasti A, Vendrell Bayona T, Tizzano EF. Cueto-González AM, et al. Genet Med. 2022 Mar;24(3):754-756. doi: 10.1016/j.gim.2021.11.007. Epub 2021 Dec 6. Genet Med. 2022. PMID: 34906509 No abstract available.